A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes.

Saved in:
Bibliographic Details
Title: A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes.
Authors: Ferrini PR, Grossi A, Vannucchi AM, Barosi G, Guarnone R, Piva N, Musto P, Balleari E
Corporate Authors: Italian Cooperative Study Group for rHuEpo in Myelodysplastic Syndromes
Source: British journal of haematology [Br J Haematol] 1998 Dec; Vol. 103 (4), pp. 1070-4.
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print Cited Medium: Print ISSN: 0007-1048 (Print) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:0007-1048
DOI:10.1046/j.1365-2141.1998.01085.x